US study finds data changes in drug companies' brochuresBMJ 2006; 332 doi: https://doi.org/10.1136/bmj.332.7541.568-c (Published 09 March 2006) Cite this as: BMJ 2006;332:568
- Michael Day
Three out of 20 brochures distributed to family doctors by drug companies exaggerated the benefit of treatments, a study published this week has found.
“We decided to do the study because pharmaceutical representatives are very active in promoting their products in our clinics and doctors often refer to them,” said the study's lead researcher, Robert Cardarelli, assistant professor of family medicine, at the University of North Texas Health Science Center, Fort Worth.
“This study shows that doctors should check the data before making changes to their prescribing.”
Together with colleagues he asked doctors in five of …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial